Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04549571 · ClinicalTrials.gov registry record · NA
Improving Patient-Centered Communication in Breast Cancer Through Patient and Provider Interventions
A NA study of Anatomic Stage III Breast Cancer AJCC v8 and Anatomic Stage II Breast Cancer AJCC v8, sponsored by Alliance for Clinical Trials in Oncology.
- Active
- Registry status
- NA
- Development phase
- 543
- Enrollment target
- 20
- Study locations
NCT04549571 is a NA study of Anatomic Stage III Breast Cancer AJCC v8 and Anatomic Stage II Breast Cancer AJCC v8 that is active but no longer recruiting, run by Alliance for Clinical Trials in Oncology. The registered enrollment target is 543 participants, above the 298-participant average among 84 other Anatomic Stage III Breast Cancer AJCC v8 trials with a reported enrollment target (82% higher). The trial reports 20 study locations across 12 states.
The verdict
NCT04549571, a NA study of Anatomic Stage III Breast Cancer AJCC v8 and Anatomic Stage II Breast Cancer AJCC v8, is active but no longer recruiting, sponsored by Alliance for Clinical Trials in Oncology.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 543 participants
- Enrollment target
- 20
- Study locations
Study Summary
This trial studies the effectiveness of two interventions on patient reported outcomes of patient centered communication and decision making about breast cancer treatment. The first intervention consists of enhancements to an existing patient-facing breast cancer treatment decision tool called iCanDecide that supports the management of worry, distress, and anxiety as compared to an existing tool. The second intervention consists of a clinician dashboard that populates information after patients view either website regarding any ongoing issues or concerns.
Conditions Studied
Interventions
- PROCEDURE Therapeutic Conventional Surgery
- OTHER Interview
- OTHER Training
- OTHER Decision Aid iCanDecide - ESE website
- OTHER Decision Aid iCanDecide - S website
Study Locations (20)
Michigan
- Corewell Health Grand Rapids Hospitals - Butterworth Hospital - Grand Rapids
- West Michigan Cancer Center - Kalamazoo
- Ascension Borgess Hospital - Kalamazoo
New York
- Northern Westchester Hospital - Mount Kisco
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center - New York
- Montefiore Medical Center-Einstein Campus - The Bronx
Ohio
- Adena Regional Medical Center - Chillicothe
- Saint Ann's Hospital - Westerville
- Genesis Healthcare System Cancer Care Center - Zanesville
Delaware
- Helen F Graham Cancer Center - Newark
- Beebe Health Campus - Rehoboth Beach
North Dakota
- Sanford Bismarck Medical Center - Bismarck
- Sanford Broadway Medical Center - Fargo
California
- Kaiser Permanente-Vallejo - Vallejo
Georgia
- Lewis Cancer and Research Pavilion at Saint Joseph's/Candler - Savannah
Hawaii
- Kaiser Permanente Moanalua Medical Center - Honolulu
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 543 participants |
| Start Date | 2021-02-16 |
| Est. Completion | 2027-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04549571
The ClinicalTrials.gov registry entry for NCT04549571 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 543 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 298-participant average among 84 other Anatomic Stage III Breast Cancer AJCC v8 trials with a reported enrollment target (82% higher). The listed sponsor is Alliance for Clinical Trials in Oncology, which has 446 total studies on file at ClinicalTrials.gov.
The record links to 10 conditions, with Anatomic Stage III Breast Cancer AJCC v8 appearing as the primary indexed condition, and to 5 interventions - of which Therapeutic Conventional Surgery is the first listed.
NCT04549571 reports 20 study locations spanning 12 distinct geographic areas - top geographies include Michigan, New York, Ohio.
Frequently Asked Questions
What is clinical trial NCT04549571 about?
NCT04549571 is a clinical study titled "Improving Patient-Centered Communication in Breast Cancer Through Patient and Provider Interventions". This trial studies the effectiveness of two interventions on patient reported outcomes of patient centered communication and decision making about breast cancer treatment. The first intervention consists of enhancements to an existing patient-facing breast cancer treatment decision tool called iCanD...
What is the current status of trial NCT04549571?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 543 participants. The study started on 2021-02-16. Estimated completion is 2027-01.
What conditions does trial NCT04549571 study?
This clinical trial studies the following conditions: Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIA Breast Cancer AJCC v8.
What interventions are being tested in trial NCT04549571?
The interventions under investigation include: Therapeutic Conventional Surgery (PROCEDURE), Interview (OTHER), Training (OTHER), Decision Aid iCanDecide - ESE website (OTHER), Decision Aid iCanDecide - S website (OTHER).
Who is sponsoring clinical trial NCT04549571?
This trial is sponsored by Alliance for Clinical Trials in Oncology, which has 446 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04549571 being conducted?
This trial has 20 study locations across California, Delaware, Georgia, Hawaii, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anatomic Stage III Breast Cancer AJCC v8
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Lymphovenous Bypass Procedure Before Underarm Lymph Node Surgery in Preventing Lymphedema in Patients With Inflammatory or Locally Advanced Non-inflammatory Breast Cancer or Melanoma
RECRUITING · NA
-
A Quality of Life Intervention for Young African American Breast Cancer Survivors in Treatment
RECRUITING · NA
-
Food for Thought - A Nutrition Intervention for Women Undergoing Active Treatment for Triple Negative Breast Cancer
RECRUITING · NA
-
Transcutaneous Electrical Nerve Stimulation in Chemotherapy Induced Peripheral Neuropathy in Patients With Stage I-III Early Stage Breast Cancer
RECRUITING · NA
-
Remotely Delivered, Community-Aligned Weight Loss Interventions Among Breast Cancer Survivors, ¡Vida! Trial
RECRUITING · NA
-
Feasibility Study of Biobehavioral Stress Reduction Intervention in Patients With Triple Negative Breast Cancer
RECRUITING · NA
Explore more on PlainTrial
Anatomic Stage III Breast Cancer AJCC v8
All registered trials for this condition
Anatomic Stage II Breast Cancer AJCC v8
All registered trials for this condition
California
All trials with a study site in California
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.